These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22208989)

  • 1. Rational design and evaluation of mammalian ribonuclease cytotoxins.
    Lomax JE; Eller CH; Raines RT
    Methods Enzymol; 2012; 502():273-90. PubMed ID: 22208989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tandemization endows bovine pancreatic ribonuclease with cytotoxic activity.
    Leich F; Köditz J; Ulbrich-Hofman R; Arnold U
    J Mol Biol; 2006 May; 358(5):1305-13. PubMed ID: 16580680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of the cytotoxic RNase A dimers with the cytosolic ribonuclease inhibitor.
    Naddeo M; Vitagliano L; Russo A; Gotte G; D'Alessio G; Sorrentino S
    FEBS Lett; 2005 May; 579(12):2663-8. PubMed ID: 15862306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-specific PEGylation endows a mammalian ribonuclease with antitumor activity.
    Rutkoski TJ; Kink JA; Strong LE; Raines RT
    Cancer Biol Ther; 2011 Aug; 12(3):208-14. PubMed ID: 21633186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional structure of a human pancreatic ribonuclease variant, a step forward in the design of cytotoxic ribonucleases.
    Pous J; Canals A; Terzyan SS; Guasch A; Benito A; Ribó M; Vilanova M; Coll M
    J Mol Biol; 2000 Oct; 303(1):49-60. PubMed ID: 11021969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytosolic RNase inhibitor only affects RNases with intrinsic cytotoxicity.
    Monti DM; D'Alessio G
    J Biol Chem; 2004 Sep; 279(38):39195-8. PubMed ID: 15277533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing the potency of a cytotoxin with an arginine graft.
    Fuchs SM; Rutkoski TJ; Kung VM; Groeschl RT; Raines RT
    Protein Eng Des Sel; 2007 Oct; 20(10):505-9. PubMed ID: 17954521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing an inhibitor unleashes a cytotoxic enzyme.
    Dickson KA; Raines RT
    Biochemistry; 2009 Jun; 48(23):5051-3. PubMed ID: 19402708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of Highly Stable Cytotoxic Nuclear-Directed Ribonucleases.
    Roura Padrosa D; Castro J; Romero-Casañas A; Ribó M; Vilanova M; Benito A
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30544927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging biological functions of ribonuclease 1 and angiogenin.
    Garnett ER; Raines RT
    Crit Rev Biochem Mol Biol; 2022 Jun; 57(3):244-260. PubMed ID: 34886717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretory ribonucleases are internalized by a dynamin-independent endocytic pathway.
    Haigis MC; Raines RT
    J Cell Sci; 2003 Jan; 116(Pt 2):313-24. PubMed ID: 12482917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of ribonuclease multimers created by site-specific covalent tethering.
    Rutkoski TJ; Kink JA; Strong LE; Schilling CI; Raines RT
    Bioconjug Chem; 2010 Sep; 21(9):1691-702. PubMed ID: 20704261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells.
    Vert A; Castro J; Ribó M; Benito A; Vilanova M
    Oncotarget; 2016 Apr; 7(14):18309-24. PubMed ID: 26918450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-Based Design: Synthesis, X-ray Crystallography, and Biological Evaluation of N-Substituted-4-Hydroxy-2-Quinolone-3-Carboxamides as Potential Cytotoxic Agents.
    Sabbah DA; Hishmah B; Sweidan K; Bardaweel S; AlDamen M; Zhong HA; Abu Khalaf R; Hasan Ibrahim A; Al-Qirim T; Abu Sheikha G; Mubarak MS
    Anticancer Agents Med Chem; 2018; 18(2):263-276. PubMed ID: 28901259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endowing human pancreatic ribonuclease with toxicity for cancer cells.
    Leland PA; Staniszewski KE; Kim BM; Raines RT
    J Biol Chem; 2001 Nov; 276(46):43095-102. PubMed ID: 11555655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel biological actions acquired by ribonuclease through oligomerization.
    Libonati M; Gotte G; Vottariello F
    Curr Pharm Biotechnol; 2008 Jun; 9(3):200-9. PubMed ID: 18673285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human angiogenin is a potent cytotoxin in the absence of ribonuclease inhibitor.
    Thomas SP; Hoang TT; Ressler VT; Raines RT
    RNA; 2018 Aug; 24(8):1018-1027. PubMed ID: 29748193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a new class of natural product MDM2 inhibitor: In vitro and in vivo anti-breast cancer activities and target validation.
    Qin JJ; Wang W; Voruganti S; Wang H; Zhang WD; Zhang R
    Oncotarget; 2015 Feb; 6(5):2623-40. PubMed ID: 25739118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocytotic internalization as a crucial factor for the cytotoxicity of ribonucleases.
    Leich F; Stöhr N; Rietz A; Ulbrich-Hofmann R; Arnold U
    J Biol Chem; 2007 Sep; 282(38):27640-6. PubMed ID: 17635931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, Characterization, and Preliminary In Vitro Cytotoxic Evaluation of a Series of 2-Substituted Benzo [
    Linares-Anaya O; Avila-Sorrosa A; Díaz-Cedillo F; Gil-Ruiz LÁ; Correa-Basurto J; Salazar-Mendoza D; Orjuela AL; Alí-Torres J; Ramírez-Apan MT; Morales-Morales D
    Molecules; 2021 May; 26(9):. PubMed ID: 34066820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.